
Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Description
Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Human Immunodeficiency Virus (HIV) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Human Immunodeficiency Virus (HIV) Tests refer to the antigens, antibodies and nucleic acid reagent tests performed for the detection of HIV type I.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Human Immunodeficiency Virus (HIV) Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Human Immunodeficiency Virus (HIV) Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Human Immunodeficiency Virus (HIV) Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
200 Pages
- 1 About GlobalData
- 2 Table of Contents
- 2.1 List of Tables
- 2.2 List of Figures
- 3 Introduction
- 3.1 Human Immunodeficiency Virus (HIV) Tests Overview
- 4 Products under Development
- 4.1 Human Immunodeficiency Virus (HIV) Tests - Pipeline Products by Stage of Development
- 4.2 Human Immunodeficiency Virus (HIV) Tests - Pipeline Products by Segment
- 4.3 Human Immunodeficiency Virus (HIV) Tests - Pipeline Products by Territory
- 4.4 Human Immunodeficiency Virus (HIV) Tests - Pipeline Products by Regulatory Path
- 4.5 Human Immunodeficiency Virus (HIV) Tests - Pipeline Products by Estimated Approval Date
- 4.6 Human Immunodeficiency Virus (HIV) Tests - Ongoing Clinical Trials
- 5 Human Immunodeficiency Virus (HIV) Tests - Pipeline Products under Development by Companies
- 5.1 Human Immunodeficiency Virus (HIV) Tests Companies - Pipeline Products by Stage of Development
- 5.2 Human Immunodeficiency Virus (HIV) Tests – Companies Pipeline Products by Stage of Development
- 6 Human Immunodeficiency Virus (HIV) Tests Companies and Product Overview
- 6.1 Abbott Rapid Diagnostics GmbH Company Overview
- 6.2 Accelevir Diagnostics LLC Company Overview
- 6.2.1 Accelevir Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.3 Aldatu Biosciences Inc Company Overview
- 6.3.1 Aldatu Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.4 Alere Inc Company Overview
- 6.4.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.5 Allied Innovative Systems, LLC Company Overview
- 6.5.1 Allied Innovative Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.6 Altratech Ltd Company Overview
- 6.6.1 Altratech Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.7 Atomo Diagnostics Ltd Company Overview
- 6.7.1 Atomo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.8 Autoimmune Technologies LLC Company Overview
- 6.8.1 Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.9 Ayanda Biosystems SA (Inactive) Company Overview
- 6.9.1 Ayanda Biosystems SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 6.10 BBB Technologies Inc Company Overview
- 6.10.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.11 Beijing Wantai Biological Pharmacy Enterprise Co Ltd Company Overview
- 6.11.1 Beijing Wantai Biological Pharmacy Enterprise Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.12 Binx Health Inc Company Overview
- 6.12.1 Binx Health Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.13 Bio-AMD Inc Company Overview
- 6.13.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.14 Biocartis Group NV Company Overview
- 6.14.1 Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview
- 6.15 BioHelix Corp Company Overview
- 6.15.1 BioHelix Corp Pipeline Products & Ongoing Clinical Trials Overview
- 6.16 Biokit SA Company Overview
- 6.16.1 Biokit SA Pipeline Products & Ongoing Clinical Trials Overview
- 6.17 Biomagnetics Diagnostics Corp Company Overview
- 6.17.1 Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
- 6.18 Blackfly Investments LLC Company Overview
- 6.18.1 Blackfly Investments LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.19 Bluejay Diagnostics Inc Company Overview
- 6.19.1 Bluejay Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.20 Calypte Biomedical Corporation Company Overview
- 6.20.1 Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview
- 6.21 Cell Microsystems Inc Company Overview
- 6.21.1 Cell Microsystems Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.22 CeMines, Inc. (Inactive) Company Overview
- 6.22.1 CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 6.23 Centre International de Reference Chantal Biya Company Overview
- 6.23.1 Centre International de Reference Chantal Biya Pipeline Products & Ongoing Clinical Trials Overview
- 6.24 Cepheid Inc Company Overview
- 6.24.1 Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.25 Chembio Diagnostic Systems Inc Company Overview
- 6.25.1 Chembio Diagnostic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.26 CHIP Diagnostics Inc Company Overview
- 6.26.1 CHIP Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.27 ChipCare Corp Company Overview
- 6.27.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
- 6.28 Co-Diagnostics Inc Company Overview
- 6.28.1 Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.29 Conrad Company Overview
- 6.29.1 Conrad Pipeline Products & Ongoing Clinical Trials Overview
- 6.30 Cornell University Company Overview
- 6.30.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview
- 6.31 CoSara Diagnostics Pvt Ltd Company Overview
- 6.31.1 CoSara Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.32 CrossLife Technologies Inc Company Overview
- 6.32.1 CrossLife Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.33 Cue Inc Company Overview
- 6.33.1 Cue Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.34 Cupid Ltd Company Overview
- 6.34.1 Cupid Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.35 Daktari Diagnostics, Inc. Company Overview
- 6.35.1 Daktari Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- 6.36 Diagnostics For All Inc Company Overview
- 6.36.1 Diagnostics For All Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.37 Diagnostics for the Real World (Europe) Ltd Company Overview
- 6.37.1 Diagnostics for the Real World (Europe) Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.38 Diagnostics for the Real World Ltd Company Overview
- 6.38.1 Diagnostics for the Real World Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.39 Discidium Biosciences LLC Company Overview
- 6.39.1 Discidium Biosciences LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.40 DNAE Group Holdings Ltd Company Overview
- 6.40.1 DNAE Group Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.41 Enable Biosciences Inc Company Overview
- 6.41.1 Enable Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.42 Endeavor Sciences Inc Company Overview
- 6.42.1 Endeavor Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.43 Enzo Biochem Inc Company Overview
- 6.43.1 Enzo Biochem Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.44 Epinex Diagnostics Inc Company Overview
- 6.44.1 Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.45 ERBA Molecular Ltd Company Overview
- 6.45.1 ERBA Molecular Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.46 Eurobio Scientific SA Company Overview
- 6.46.1 Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview
- 6.47 Fast Track Diagnostics Ltd Company Overview
- 6.47.1 Fast Track Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.48 Fluxergy LLC Company Overview
- 6.48.1 Fluxergy LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.49 Fujirebio Diagnostics Inc Company Overview
- 6.49.1 Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.50 G Medical Health and Wellness Company Overview
- 6.50.1 G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview
- 6.51 GAIA Medical Institute LLC Company Overview
- 6.51.1 GAIA Medical Institute LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.52 genedrive plc Company Overview
- 6.52.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
- 6.53 Genome Diagnostics Pvt Ltd Company Overview
- 6.53.1 Genome Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.54 Goodgene Inc Company Overview
- 6.54.1 Goodgene Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.55 Group K Diagnostics Company Overview
- 6.55.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
- 6.56 Guangzhou Wondfo Biotech Co Ltd Company Overview
- 6.56.1 Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.57 HA TECH Pty Ltd Company Overview
- 6.57.1 HA TECH Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.58 HeatFlow Technologies Inc Company Overview
- 6.58.1 HeatFlow Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.59 Identifysensors LLC Company Overview
- 6.59.1 Identifysensors LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.60 Immunetics Inc Company Overview
- 6.60.1 Immunetics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.61 Imperial College London Company Overview
- 6.61.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
- 6.62 Institute for Development Research Company Overview
- 6.62.1 Institute for Development Research Pipeline Products & Ongoing Clinical Trials Overview
- 6.63 Integrated Diagnostics Inc (Inactive) Company Overview
- 6.63.1 Integrated Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 6.64 Intelligent Bio Solutions Inc Company Overview
- 6.64.1 Intelligent Bio Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.65 Intuitive Biosciences Inc Company Overview
- 6.65.1 Intuitive Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.66 Invex Health Pvt Ltd Company Overview
- 6.66.1 Invex Health Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.67 IRIS International Inc Company Overview
- 6.67.1 IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.68 Jan Biotech Inc Company Overview
- 6.68.1 Jan Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.69 Jinvator Bio Med GmbH Company Overview
- 6.69.1 Jinvator Bio Med GmbH Pipeline Products & Ongoing Clinical Trials Overview
- 6.70 Johns Hopkins University Company Overview
- 6.70.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
- 6.71 Maxim Biomedical Inc Company Overview
- 6.71.1 Maxim Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.72 MedMira Inc Company Overview
- 6.72.1 MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.73 MedNostic Technologies, LLC Company Overview
- 6.73.1 MedNostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.74 Medosome Biotec LLC Company Overview
- 6.74.1 Medosome Biotec LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.75 Micronics Inc Company Overview
- 6.75.1 Micronics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.76 Minute Molecular Diagnostics Inc Company Overview
- 6.76.1 Minute Molecular Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.77 MND Diagnostic LTD Company Overview
- 6.77.1 MND Diagnostic LTD Pipeline Products & Ongoing Clinical Trials Overview
- 6.78 Molbio Diagnostics Pvt Ltd Company Overview
- 6.78.1 Molbio Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.79 MyMD Pharmaceuticals Inc Company Overview
- 6.79.1 MyMD Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.80 Nanobiosym Inc Company Overview
- 6.80.1 Nanobiosym Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.81 NeuMoDx Molecular Inc Company Overview
- 6.81.1 NeuMoDx Molecular Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.82 Newmark Diagnostics LLC Company Overview
- 6.82.1 Newmark Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.83 Northwestern University Company Overview
- 6.83.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
- 6.84 Odyssey Thera, inc. (Inactive) Company Overview
- 6.84.1 Odyssey Thera, inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 6.85 Oregon Health & Science University Company Overview
- 6.85.1 Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview
- 6.86 Osel Inc Company Overview
- 6.86.1 Osel Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.87 Paramedical Srl Company Overview
- 6.87.1 Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview
- 6.88 Pathogenica Inc Company Overview
- 6.88.1 Pathogenica Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.89 PATHseq Diagnostics Inc Company Overview
- 6.89.1 PATHseq Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.90 PixCell Medical Technologies Ltd Company Overview
- 6.90.1 PixCell Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.91 Prenetics Ltd Company Overview
- 6.91.1 Prenetics Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.92 Purdue University Company Overview
- 6.92.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview
- 6.93 QuantuMDx Group Ltd Company Overview
- 6.93.1 QuantuMDx Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.94 Quidel Corp Company Overview
- 6.94.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview
- 6.95 Radisens Diagnostics Ltd Company Overview
- 6.95.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.96 Rheonix Inc Company Overview
- 6.96.1 Rheonix Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.97 Rice University Company Overview
- 6.97.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview
- 6.98 Roche Diagnostics International Ltd Company Overview
- 6.98.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.99 Seattle Children’s Hospital Company Overview
- 6.99.1 Seattle Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview
- 6.100 Sedia Biosciences Corp Company Overview
- 6.100.1 Sedia Biosciences Corp Pipeline Products & Ongoing Clinical Trials Overview
- 6.101 Seegene Inc Company Overview
- 6.101.1 Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.102 Senzo Inc Company Overview
- 6.102.1 Senzo Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.103 Shenzhen New Industries Biomedical Engineering Co Ltd Company Overview
- 6.103.1 Shenzhen New Industries Biomedical Engineering Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.104 Siemens Healthineers AG Company Overview
- 6.104.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
- 6.105 Stanford University Company Overview
- 6.105.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
- 6.106 Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview
- 6.106.1 Syamala Srinivasa Life Sciences Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.107 Taizhou ZECEN Biotech Co Ltd Company Overview
- 6.107.1 Taizhou ZECEN Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.108 TBG Diagnostics Ltd Company Overview
- 6.108.1 TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.109 TheoremDx Inc Company Overview
- 6.109.1 TheoremDx Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.110 TheraDiag SA Company Overview
- 6.110.1 TheraDiag SA Pipeline Products & Ongoing Clinical Trials Overview
- 6.111 Trinity Biotech Plc Company Overview
- 6.111.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview
- 6.112 University of California San Diego Company Overview
- 6.112.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
- 6.113 University of Connecticut Company Overview
- 6.113.1 University of Connecticut Pipeline Products & Ongoing Clinical Trials Overview
- 6.114 University of Michigan Company Overview
- 6.114.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
- 6.115 University of Minnesota Company Overview
- 6.115.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
- 6.116 University of the Philippines Manila Company Overview
- 6.116.1 University of the Philippines Manila Pipeline Products & Ongoing Clinical Trials Overview
- 6.117 University of Washington Company Overview
- 6.117.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview
- 6.118 UrSure Inc Company Overview
- 6.118.1 UrSure Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.119 Ustar Biotechnologies (Hangzhou) Ltd. Company Overview
- 6.119.1 Ustar Biotechnologies (Hangzhou) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
- 6.120 VEGA Ltd Company Overview
- 6.120.1 VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.121 Wave 80 Biosciences Inc Company Overview
- 6.121.1 Wave 80 Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.122 Yaathum Biotech Pvt Ltd Company Overview
- 6.122.1 Yaathum Biotech Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 7 Human Immunodeficiency Virus (HIV) Tests- Recent Developments
- 7.1 May 01, 2023: Gilead sciences announces launch of Asia pacific rainbow grant 2023
- 7.2 Apr 26, 2023: George Washington University Hosting Webinar on HIV Testing and Screening Guidelines
- 7.3 Mar 02, 2023: UConn Researcher Develops Simple, Affordable HIV Testing Device
- 7.4 Feb 23, 2023: Weill Cornell Medicine awarded NCI grant for EBV-related lymphoma research
- 7.5 Feb 20, 2023: Maternova and MedMira enter distribution agreement to market rapid diagnostics for HIV, syphilis and hepatitis
- 7.6 Feb 15, 2023: Thermo Fisher Scientific launches PCR kits for infectious disease detection in India
- 7.7 Jan 10, 2023: IIT-Goa to research on cost-effective, faster detection of HIV, tuberculosis
- 7.7.1 6.8 Aug 08, 2022: Thermo Fisher Scientific launches enhanced Applied Biosystems HIV-1 genotyping kit
- 8 Appendix
- 8.1 Methodology
- 8.2 About GlobalData
- 8.3 Contact Us
- 8.4 Disclaimer
- 2.1 List of Tables
- Table 1: Human Immunodeficiency Virus (HIV) Tests - Pipeline Products by Stage of Development
- Table 2: Human Immunodeficiency Virus (HIV) Tests - Pipeline Products by Segment
- Table 3: Human Immunodeficiency Virus (HIV) Tests - Pipeline Products by Territory
- Table 4: Human Immunodeficiency Virus (HIV) Tests - Pipeline Products by Regulatory Path
- Table 5: Human Immunodeficiency Virus (HIV) Tests - Pipeline Products by Estimated Approval Date
- Table 6: Human Immunodeficiency Virus (HIV) Tests - Ongoing Clinical Trials
- Table 7: Human Immunodeficiency Virus (HIV) Tests Companies - Pipeline Products by Stage of Development
- Table 8: Human Immunodeficiency Virus (HIV) Tests – Companies Pipeline Products by Stage of Development
- Table 9: Abbott Rapid Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
- Table 10: Urine Tenofovir Rapid Assay - Product Status
- Table 11: Urine Tenofovir Rapid Assay - Product Description
- Table 12: Abbott Rapid Diagnostics GmbH - Ongoing Clinical Trials Overview
- Table 13: Urine Tenofovir Rapid Assay - Urine Tenofovir Point-of-care Test to Identify Patients in Need of ART Adherence Support (UTRA Study)
- Table 14: Accelevir Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 15: Diagnostic Test - Latent HIV-1 Virus - Product Status
- Table 16: Diagnostic Test - Latent HIV-1 Virus - Product Description
- Table 17: HIV Persistent Proviruses Transcriptional Activity Detection Test - Product Status
- Table 18: HIV Persistent Proviruses Transcriptional Activity Detection Test - Product Description
- Table 19: HIV Residual Viremia Assay - Product Status
- Table 20: HIV Residual Viremia Assay - Product Description
- Table 21: HIV-1 EnvLRS Assay - Product Status
- Table 22: HIV-1 EnvLRS Assay - Product Description
- Table 23: Aldatu Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 24: Pandaa HIV6 - Product Status
- Table 25: Pandaa HIV6 - Product Description
- Table 26: PANDAA HIVDR Minor Variants - Product Status
- Table 27: PANDAA HIVDR Minor Variants - Product Description
- Table 28: PANDAA HIVDR PI+ - Product Status
- Table 29: PANDAA HIVDR PI+ - Product Description
- Table 30: PANDAA HIVDR RTI - Product Status
- Table 31: PANDAA HIVDR RTI - Product Description
- Table 32: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 33: AIMS System - HIV-1 Test - Product Status
- Table 34: AIMS System - HIV-1 Test - Product Description
- Table 35: AtheNA Multi-Lyte System - HIV-1 Test - Product Status
- Table 36: AtheNA Multi-Lyte System - HIV-1 Test - Product Description
- Table 37: Allied Innovative Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 38: HIV p24 Antigen ELISA - Product Status
- Table 39: HIV p24 Antigen ELISA - Product Description
- Table 40: Altratech Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 41: Point-Of-Care Test - HIV Infection - Product Status
- Table 42: Point-Of-Care Test - HIV Infection - Product Description
- Table 43: Atomo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 44: Atomo HIV Self Test - Product Status
- Table 45: Atomo HIV Self Test - Product Description
- Table 46: AtomoRapid HIV - Product Status
- Table 47: AtomoRapid HIV - Product Description
- Table 48: Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 49: Viral Protein Antibody Test - Non-HIV AIDS - Product Status
- Table 50: Viral Protein Antibody Test - Non-HIV AIDS - Product Description
- Table 51: Ayanda Biosystems SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- Table 52: DETECTHIV - Product Status
- Table 53: DETECTHIV - Product Description
- Table 54: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 55: Mobile RDT Reader - HIV1/2 Test - Product Status
- Table 56: Mobile RDT Reader - HIV1/2 Test - Product Description
- Table 57: Beijing Wantai Biological Pharmacy Enterprise Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 58: Urine Based Rapid HIV Test - Product Status
- Table 59: Urine Based Rapid HIV Test - Product Description
- Table 60: Binx Health Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 61: Atlas io System - HIV Assay - Product Status
- Table 62: Atlas io System - HIV Assay - Product Description
- Table 63: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 64: Digital Strip Reader - HIV Test - Product Status
- Table 65: Digital Strip Reader - HIV Test - Product Description
- Table 66: Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview
- Table 67: Idylla Viral Load Assay - HIV - Product Status
- Table 68: Idylla Viral Load Assay - HIV - Product Description
- Table 69: BioHelix Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 70: IsoAmp HIV-1 Quantitative Assay - Product Status
- Table 71: IsoAmp HIV-1 Quantitative Assay - Product Description
- Table 72: Biokit SA Pipeline Products & Ongoing Clinical Trials Overview
- Table 73: BIO-FLASH HIV-1+2 Ag/Ab Assay - Product Status
- Table 74: BIO-FLASH HIV-1+2 Ag/Ab Assay - Product Description
- Table 75: Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 76: Diagnostic Test - HIV - Product Status(Biomagnetics Diagnostics Corp)
- Table 77: Diagnostic Test - HIV - Product Description(Biomagnetics Diagnostics Corp)
- Table 78: IOBS - HIV Diagnostic Test - Product Status
- Table 79: IOBS - HIV Diagnostic Test - Product Description
- Table 80: Blackfly Investments LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 81: Molecular RNA Test - HIV - Product Status
- Table 82: Molecular RNA Test - HIV - Product Description
- Table 83: Bluejay Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 84: HIV POC Test - Product Status
- Table 85: HIV POC Test - Product Description
- Table 86: Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview
- Table 87: Aware 2 HIV-1/2 - Product Status
- Table 88: Aware 2 HIV-1/2 - Product Description
- Table 89: Aware HIV-1/2 OMT - Product Status
- Table 90: Aware HIV-1/2 OMT - Product Description
- Table 91: Second Generation Incidence Test - HIV - Product Status
- Table 92: Second Generation Incidence Test - HIV - Product Description
- Table 93: Cell Microsystems Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 94: Diagnostic Assay - Latent HIV Reservoir - Product Status
- Table 95: Diagnostic Assay - Latent HIV Reservoir - Product Description
- Table 96: CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- Table 97: Diagnostic Test - HIV - Product Status
- Table 98: Diagnostic Test - HIV - Product Description
- Table 99: Centre International de Reference Chantal Biya Pipeline Products & Ongoing Clinical Trials Overview
- Table 100: Point-Of-Care Diagnostic Test - HIV-1 - Product Status
- Table 101: Point-Of-Care Diagnostic Test - HIV-1 - Product Description
- Table 102: Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 103: GeneXpert Omni - HIV-1 Qualitative Test - Product Status
- Table 104: GeneXpert Omni - HIV-1 Qualitative Test - Product Description
- Table 105: GeneXpert Omni - HIV-1 Viral Load Test - Product Status
- Table 106: GeneXpert Omni - HIV-1 Viral Load Test - Product Description
- Table 107: Xpert HIV Quant Assay - Product Status
- Table 108: Xpert HIV Quant Assay - Product Description
- Table 109: Chembio Diagnostic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 110: DPP HIV Ag-Ab Assay - Product Status
- Table 111: DPP HIV Ag-Ab Assay - Product Description
- Table 112: DPP HIV-Syphilis Assay - Product Status
- Table 113: DPP HIV-Syphilis Assay - Product Description
- Table 114: Chembio Diagnostic Systems Inc - Ongoing Clinical Trials Overview
- Table 115: DPP HIV-Syphilis Assay - Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC): Performance Evaluation of Novel POC HIV Tests in Baltimore
- Table 116: CHIP Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 117: ExoTENPO - HIV Assay - Product Status
- Table 118: ExoTENPO - HIV Assay - Product Description
- Table 119: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 120: CD4 Assay - HIV - Product Status
- Table 121: CD4 Assay - HIV - Product Description
- Table 122: Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 123: HIV RNA Real-time PCR Kit - Product Status
- Table 124: HIV RNA Real-time PCR Kit - Product Description
- Table 125: Conrad Pipeline Products & Ongoing Clinical Trials Overview
- Table 126: Biomarker - HIV Acquisition - Product Status
- Table 127: Biomarker - HIV Acquisition - Product Description
- Table 128: Cornell University Pipeline Products & Ongoing Clinical Trials Overview
- Table 129: Diagnostic Test - Acute HIV Infection - Product Status
- Table 130: Diagnostic Test - Acute HIV Infection - Product Description
- Table 131: CoSara Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 132: Viral Load Test - HIV - Product Status
- Table 133: Viral Load Test - HIV - Product Description
- Table 134: CrossLife Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 135: TARApen Test - Product Status
- Table 136: TARApen Test - Product Description
- Table 137: Cue Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 138: Cue HIV Viral Load Test - Product Status
- Table 139: Cue HIV Viral Load Test - Product Description
- Table 140: Cupid Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 141: HIV ½ Ab Test - Product Status
- Table 142: HIV ½ Ab Test - Product Description
- Table 143: Daktari Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- Table 144: Aspect - HIV Viral Load Test - Product Status
- Table 145: Aspect - HIV Viral Load Test - Product Description
- Table 146: Diagnostics For All Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 147: Paper-Based Microfluidic Device - HIV - Product Status
- Table 148: Paper-Based Microfluidic Device - HIV - Product Description
- Table 149: Diagnostics for the Real World (Europe) Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 150: SAMBA - HIV-1 Viral Load Assay - Product Status
- Table 151: SAMBA - HIV-1 Viral Load Assay - Product Description
- Table 152: SAMBA VL - Product Status
- Table 153: SAMBA VL - Product Description
- Table 154: SAS - HIV Assay - Product Status
- Table 155: SAS - HIV Assay - Product Description
- Table 156: Diagnostics for the Real World Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 157: SAMBA III - Product Status
- Table 158: SAMBA III - Product Description
- Table 159: Discidium Biosciences LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 160: Screening Test - HIV Drug Resistance - Product Status
- Table 161: Screening Test - HIV Drug Resistance - Product Description
- Table 162: DNAE Group Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 163: USB Stick-Based HIV Test - Product Status
- Table 164: USB Stick-Based HIV Test - Product Description
- Table 165: Enable Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 166: ADAP HIV Assay - Product Status
- Table 167: ADAP HIV Assay - Product Description
- Table 168: Endeavor Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 169: Rapid Immunoassay Test - HIV 1 And 2 - Product Status
- Table 170: Rapid Immunoassay Test - HIV 1 And 2 - Product Description
- Table 171: Enzo Biochem Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 172: AmpiProbe HIV Viral Load Assay - Product Status
- T
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.